Live attenuated vaccine

55 marketed 58 in Phase 3 2 in Phase 2

This page covers all Live attenuated vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Mumps virus surface antigens, Poliovirus type 2, Varicella-zoster virus (VZV).

Targets

Mumps virus surface antigens · Poliovirus type 2 · Varicella-zoster virus (VZV) · Measles virus surface glycoproteins (H and F proteins) · Hepatitis A virus · Rotavirus VP4 and VP7 surface proteins · Vaccinia virus antigens (envelope and intracellular proteins) · Varicella-zoster virus · Poliovirus serotypes 1 and 3 · Poliovirus type 1

Marketed (55)

Phase 3 pipeline (58)

Phase 2 pipeline (2)